Hans Friberg is the chair of the board and a well-renowned key opinion leader within the field of therapeutic hypothermia. He is one of the authors of the randomized multi-center study Targeted Temperature Management at 33 degrees C versus 36 degrees C after Cardiac Arrest, published in New England Journal of Medicine (2013).
The study showed that there was no significant difference in survival rate between cooling patients to 33°C or 36°C. However, the results were significant enough to result in new worldwide guidelines for cooling after a cardiac arrest. (Study link).
Tadeusz Wieloch’s research team focuses on studies of mechanisms of brain damage after cardiac arrest and stroke, as well as mechanisms of functional recovery of the brain after injury. The research is conducted experimentally and translationally with a view to develop new treatments that prevent brain damage or improve brain function. He has published over 200 scientific articles in this field since 1981.
User Advisory Board
In parallel to establishing a scientific advisory board, QuickCool has also established a User Advisory Board to ensure that user needs and desires are met.
The core of the QuickCool User Advisory Board consists of handpicked individuals who are all active at hospitals in Skåne and have many years of experience in the field of Targeted Temperature Management TTM (Therapeutic Hypothermia). This ensures that we have good insight into the day-to-day work and requirements of our future users and that the product we develop is exactly what the user needs and desires.
In addition to TTM professionals, the QuickCool User Advisory Board also includes industrial designers, engineers and project leaders, and forms the backbone of the QuickCool development process.